Publication: The treatment outcomes of oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: a multi-institutional analysis TROD 02-008
Program
KU-Authors
KU Authors
Co-Authors
Guler, O. C.
Hurmuz, P.
Atalar, B.
Guney, Y. Yukselen
Saglam, E. K.
Akyurek, S.
Gural, Z.
Tugrul, F.
Korcum, A. F.
Sen, C. A.
Publication Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Purpose/Objective(s):Stereotacticbodyradiotherapy(SBRT) is increasinglybeingusedtotreatoligometastaticcancers,buthigh-levelevidenceto supportpolicydecisions is lacking inpatientswithcolorectal carcinoma (CRC).Thepurposeof thisstudywastodeterminetheprognosticfactors forsurvival inoligometastaticcolorectalcancerpatientstreatedwithSBRT inamulticentricsetting. Materials/Methods:Theclinicaldataof437oligometastaticCRCpatients whoreceivedmetastasisdirectedtreatment(MDT)viaSBRTat18institutionsbetweenFebruary2007andFebruary2021werereviewedretrospectively.Patientseitherhaddenovooligometastasis (≤5metastases)at the timeofdiagnosisorhadoligometastaticrecurrencesduringfollow-up.All patientswere treatedwith the goal of curing theirmetastasis, and839 lesionswereirradiated. Results:Theaverageagewas61years(range;27-92years).Themajorityof patients(58.8%)hadcoloncarcinomawithasingleorganmetastasis(88.8 %).Theaveragenumberofmetastatic lesionswas2(range, 1-5).There were103patientswithlivermetastasis,222patientswithlungmetastasis, 58patientswithlymphnodemetastasis,60patientswithbonemetastasis, 32patientswithbrainmetastasis,and6patientswithotherorganmetastasis.BeforeRT,themedianCEAandCa-19-9levelswere5.16ng/mL(range: 0-8181.1ng/mL)and19.4(range:0.60-3693), respectively.AfterRT, the medianCEAandCa-19-9were5.00ng/mL(range,0.4-5693vng/mL)and 18(range,0-6577),respectively.Theaverageperiodoffollow-upwas15.2 months(range,0.3-91.5months).TheratesofOSandPFSaftertwoyears were 76.3% and 28.1%, respectively. Age (p<0.001), pre-RTCEA (p=0.006),pre-RTCa19-9(p=0.02),post-RTCEA(p=0.01), andpost-RT Ca19-9(p=0.02)wereallsignificantprognosticfactorsforOSinunivariate analysis.Age (HR=1.03, 95%CI, 1.01-1.04, p=0.004) andpre-RTCEA (HR=1.01,95%CI,1.00-1.02,p=0.04)wereindependentpredictorsofOS inmultivariateanalysis,whilepost-RTCEA(HR=1.93,95%CI,1.28-2.90, p=0.002)wasanindependentpredictorofPFS. Conclusion: SBRTtooligometastatic lesionswas foundtobeasafeand effective treatmentmodality forpatientswithcolorectal cancer. Survival waspredictedbyage, baselineCEA, and theCa19-9response toMDT. Additionalprospectivestudieswithlargercohortsarenecessarytovalidate ourfindings.
Source
Publisher
Elsevier
Subject
Oncology, Radiology, Nuclear medicine, Medical imaging
Citation
Has Part
Source
International Journal of Radiation Oncology Biology Physics